HomeCompareICPY vs JNJ

ICPY vs JNJ: Dividend Comparison 2026

ICPY yields 0.27% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ICPY wins by $24.00 in total portfolio value
10 years
ICPY
ICPY
● Live price
0.27%
Share price
$11.47
Annual div
$0.03
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$27.34
Full ICPY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ICPY vs JNJ

📍 ICPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodICPYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ICPY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ICPY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ICPY
Annual income on $10K today (after 15% tax)
$22.83/yr
After 10yr DRIP, annual income (after tax)
$23.24/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $680.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ICPY + JNJ for your $10,000?

ICPY: 50%JNJ: 50%
100% JNJ50/50100% ICPY
Portfolio after 10yr
$20.0K
Annual income
$427.56/yr
Blended yield
2.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ICPY
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ICPY buys
0
JNJ buys
0
No recent congressional trades found for ICPY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricICPYJNJ
Forward yield0.27%3.36%
Annual dividend / share$0.03$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.0K$20.0K
Annual income after 10y$27.34$827.78
Total dividends collected$271.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ICPY vs JNJ ($10,000, DRIP)

YearICPY PortfolioICPY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,727$26.86$10,676$355.77+$51.00ICPY
2$11,505$26.93$11,407$389.39+$98.00ICPY
3$12,337$26.99$12,198$426.53+$139.00ICPY
4$13,228$27.05$13,056$467.62+$172.00ICPY
5$14,181$27.11$13,987$513.12+$194.00ICPY
6$15,200$27.16$14,998$563.56+$202.00ICPY
7$16,292$27.21$16,098$619.52+$194.00ICPY
8$17,459$27.25$17,295$681.69+$164.00ICPY
9$18,709$27.30$18,599$750.82+$110.00ICPY
10$20,046$27.34$20,022$827.78+$24.00ICPY

ICPY vs JNJ: Complete Analysis 2026

ICPYStock

ICPY actively invests in undervalued equity securities globally, targeting firms with insider purchases or opportunistic share buybacks trading below estimated intrinsic value. Insiders include corporate officers and controlling shareholders, identified through public filings. In identifying securities, the adviser uses a quantitative, decision-rule-based process and applies additional screens to evaluate liquidity, free will insider purchases, and intrinsic value of various companies. A systematic buy-sell discipline is also employed, utilizing a quantitative multifactor comparison system informed by proprietary models and qualitative value analysis, to update and refresh the portfolio. This comparison system aids in investment decisions, prioritizing higher-scoring stocks and selling lower-scoring ones. Diversification is maintained across industries, geographies, and market caps, with position sizes generally capped at 2%. The fund seeks long-term capital growth.

Full ICPY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ICPY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ICPY vs SCHDICPY vs JEPIICPY vs OICPY vs KOICPY vs MAINICPY vs ABBVICPY vs MRKICPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.